Literature DB >> 7424954

Low sweat electrolytes in a patient with cystic fibrosis.

P B Davis, V S Hubbard, P A Di Sant'Agnese.   

Abstract

A patient with the clinical syndrome of cystic fibrosis characterized by chronic pulmonary disease, infection with mucoid Pseudomonas aeruginosa, sinusitis, nasal polyposis, abnormal pancreatic bicarbonate response to secretin stimulation, but normal levels of trypsin and chymotrypsin in the duodenal drainage, and a sibling with autopsy-documented cystic fibrosis, is described. Sweat chloride ranged from 20 to 44 meq/liter and sweat sodium from 36 to 55 meq/liter. Immunoglobulin deficiency, alpha 1-antitrypsin deficiency, tuberculosis and abnormalities of ciliary ultrastructure were excluded. Review of sweat electrolytes in 213 patients with cystic fibrosis revealed that patients with normal pancreatic enzyme release have significantly lower sweat sodium and chloride concentrations (p < 0.0005) than do patients with pancreatic insufficiency. Chronic pulmonary disease, pancreatic insufficiency and elevated levels of sweat electrolytes comprise the classic diagnostic triad for cystic fibrosis. The expression of these features may be variable, but the sweat test remains the cardinal laboratory confirmation of the diagnosis. Over 98 percent of patients with cystic fibrosis have sweat chloride values greater than 60 meq/liter, 1 to 2 percent between 50 and 60 meq/liter, and only about one in 1,000, like our patient, less than 50 meq/liter. Patients with cystic fibrosis with borderline sweat chloride values frequently have chronic pulmonary disease but intact pancreatic enzyme release. In such patients, family history, ancillary clinical features and systemic exclusion of other syndromes assume special diagnostic importance.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7424954     DOI: 10.1016/0002-9343(80)90482-9

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  7 in total

1.  Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in allergic bronchopulmonary aspergillosis.

Authors:  P W Miller; A Hamosh; M Macek; P A Greenberger; J MacLean; S M Walden; R G Slavin; G R Cutting
Journal:  Am J Hum Genet       Date:  1996-07       Impact factor: 11.025

2.  The sweat test.

Authors:  J M Littlewood
Journal:  Arch Dis Child       Date:  1986-11       Impact factor: 3.791

3.  Search for mutations in pancreatic sufficient cystic fibrosis Italian patients: detection of 90% of molecular defects and identification of three novel mutations.

Authors:  V Brancolini; L Cremonesi; E Belloni; E Pappalardo; R Bordoni; M Seia; S Russo; R Padoan; A Giunta; M Ferrari
Journal:  Hum Genet       Date:  1995-09       Impact factor: 4.132

4.  Pancreatitis as initial presentation of cystic fibrosis in young adults. A report of two cases.

Authors:  T J Masaryk; E Achkar
Journal:  Dig Dis Sci       Date:  1983-10       Impact factor: 3.199

5.  Comparison of the diagnostic value of serum pancreatic isoamylase and immunoreactive trypsin measurement in patients with cystic fibrosis.

Authors:  R C Brown; D M Chalmers; V L Rowe; J Kelleher; J M Littlewood; M S Losowsky
Journal:  J Clin Pathol       Date:  1982-05       Impact factor: 3.411

6.  Sequence analysis of the cystic fibrosis gene in patients with disseminated bronchiectatic lung disease. Application in the identification of a cystic fibrosis patient with atypical clinical course.

Authors:  W Poller; J P Faber; S Scholz; K Olek; K M Müller
Journal:  Klin Wochenschr       Date:  1991-09-16

Review 7.  Relapsing pancreatitis as initial manifestation of cystic fibrosis in a young man without pulmonary disease.

Authors:  V Gross; J Schoelmerich; K Denzel; W Gerok
Journal:  Int J Pancreatol       Date:  1989-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.